ALV.NYSEAutoliv INC

Form 4: Autoliv EVP & CTO Fabien Dumont Reports Accrual of Additional Restricted Stock Units

Sentiment:

Insider Transaction Disclosure


Autoliv, Inc.'s Executive Vice President and Chief Technology Officer, Fabien Dumont, has reported the acquisition of additional restricted stock units (RSUs) through dividend equivalent rights on existing grants.

Summary

  • Fabien Dumont, EVP & Chief Technology Officer of Autoliv, Inc. (ALV), reported transactions on June 10, 2025, involving the acquisition of additional restricted stock units (RSUs).
  • These acquisitions are a result of dividend equivalent rights accruing on previously granted performance-based and standard restricted stock units.
  • Specifically, Mr. Dumont acquired 4.5689 additional Performance-Based Restricted Stock Units from a 2023 grant, bringing his total beneficial ownership for this grant to 709.0326 units.
  • An additional 1.3019 Performance-Based Restricted Stock Units were acquired from a 2024 grant, increasing the total for this grant to 202.0303 units.
  • Further acquisitions include 1.5186, 1.1944, and 3.3132 additional Restricted Stock Units, bringing the respective totals to 235.6622, 185.3489, and 514.1599 units.
  • Each RSU represents a contingent right to receive one share of ALV common stock, with a reported acquisition price of $0 for these dividend-equivalent units.
  • The performance-based RSUs from the 2023 grant are expected to vest after the third one-year performance period ending December 31, 2025, subject to certification of performance objectives.
  • The performance-based RSUs from the 2024 grant are expected to vest after the third one-year performance period ending December 31, 2026, subject to certification of performance objectives.
  • Other Restricted Stock Units have vesting dates on February 15, 2026, February 20, 2027, and February 21, 2028.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation disclosure, but the accrual of additional RSUs through dividend equivalents is a positive for the executive and aligns their interests with shareholders, indicating a stable compensation structure.

Positives

  • The accrual of additional Restricted Stock Units (RSUs) through dividend equivalent rights increases the executive's potential future equity stake in Autoliv, Inc.
  • This mechanism aligns the executive's interests with those of shareholders, as the value of these additional RSUs is tied to the company's common stock and dividend payments.
  • The performance-based nature of some RSUs incentivizes the executive to achieve specific company objectives, potentially driving future growth and profitability.

Risks

  • The vesting of performance-based Restricted Stock Units is contingent upon the achievement of specific performance objectives, meaning the full number of units may not ultimately convert to shares if targets are not met.
  • The value of the RSUs upon vesting is dependent on the future market price of Autoliv common stock, introducing market price risk.

Future Outlook

The future outlook involves the vesting of the performance-based Restricted Stock Units (RSUs) after the completion of their respective three-year performance periods ending December 31, 2025, and December 31, 2026, contingent on the certification of performance objectives. Other standard RSUs are scheduled to vest on specific dates in February 2026, 2027, and 2028.

Industry Context

This Form 4 filing details a routine executive compensation event, specifically the accrual of additional Restricted Stock Units (RSUs) due to dividend equivalent rights. This practice is common across various industries for aligning executive incentives with shareholder returns and long-term company performance. It does not provide broader industry trends or competitive insights.

Stakeholder Impact

  • Shareholders: The RSU grants, particularly those with performance conditions and dividend equivalent rights, align the interests of the EVP & CTO with long-term shareholder value creation and dividend policy.
  • Employees: This filing pertains specifically to executive compensation and does not directly impact the broader employee base beyond setting a precedent for executive incentive structures.

Next Steps

  • Completion of the third one-year performance period for 2023 Performance-Based RSUs by December 31, 2025, followed by certification of performance objectives for vesting.
  • Completion of the third one-year performance period for 2024 Performance-Based RSUs by December 31, 2026, followed by certification of performance objectives for vesting.
  • Vesting of standard Restricted Stock Units on February 15, 2026, February 20, 2027, and February 21, 2028.

Key Dates

DateDescription
06/10/2025Date of earliest transaction for the acquisition of additional Restricted Stock Units (RSUs) due to dividend equivalent rights.
12/31/2025End of the third one-year performance period for the 2023 Performance-Based Restricted Stock Units, after which they may vest upon certification.
02/15/2026Vesting date for a portion of the Restricted Stock Units.
12/31/2026End of the third one-year performance period for the 2024 Performance-Based Restricted Stock Units, after which they may vest upon certification.
02/20/2027Vesting date for a portion of the Restricted Stock Units.
02/21/2028Vesting date for a portion of the Restricted Stock Units.
06/11/2025Signature date of the Form 4 filing by Brian Kelly, acting as Power of Attorney for Fabien Dumont.

Keywords

Autoliv, ALV, SEC Form 4, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Dividend Equivalent Rights, Performance-Based RSUs, Fabien Dumont

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.